Terms: = Gastric cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED
47 results:
1. CRISPR/Cas9 Screen in gastric cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability.
Mircetic J; Camgöz A; Abohawya M; Ding L; Dietzel J; Tobar SG; Paszkowski-Rogacz M; Seidlitz T; Schmäche T; Mehnert MC; Sidorova O; Weitz J; Buchholz F; Stange DE
Small Methods; 2023 Jun; 7(6):e2201605. PubMed ID: 36908010
[TBL] [Abstract] [Full Text] [Related]
2. Macronutrients Intake and Risk of Stomach cancer: Findings from Case-Control Study.
Allehdan S; Bassil M; Alatrash RM; Al-Jaberi T; Hushki A; Rayyan Y; Dahoud M; Abu-EIteen K; Tayyem RF
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745103
[TBL] [Abstract] [Full Text] [Related]
3. Silencing of Long Non-coding RNA LINC01106 Represses Malignant Behaviors of gastric cancer Cells by Targeting miR-34a-5p/mycn Axis.
Hong S; Li Q; Yang Y; Jing D; Zhu F
Mol Biotechnol; 2022 Feb; 64(2):144-155. PubMed ID: 34550549
[TBL] [Abstract] [Full Text] [Related]
4. NDRG1 regulates Filopodia-induced Colorectal cancer invasiveness via modulating CDC42 activity.
Aikemu B; Shao Y; Yang G; Ma J; Zhang S; Yang X; Hong H; Yesseyeva G; Huang L; Jia H; Wang C; Zang L; Sun J; Zheng M
Int J Biol Sci; 2021; 17(7):1716-1730. PubMed ID: 33994856
[TBL] [Abstract] [Full Text] [Related]
5. High expression of NDRG3 correlates with poor prognosis in gastric cancer patients.
Liu Y; Xia J; Zhou Y; Shao S
Rev Esp Enferm Dig; 2021 Jul; 113(7):524-528. PubMed ID: 33562989
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
Koh J; Nam SK; Kwak Y; Kim G; Kim KK; Lee BC; Ahn SH; Park DJ; Kim HH; Park KU; Kim WH; Lee HS
J Pathol; 2021 Jan; 253(1):94-105. PubMed ID: 32985687
[TBL] [Abstract] [Full Text] [Related]
7. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
8. Thymidylate synthase inhibitor raltitrexed can induce high levels of DNA damage in mycn-amplified neuroblastoma cells.
Yamashita K; Kiyonari S; Tsubota S; Kishida S; Sakai R; Kadomatsu K
Cancer Sci; 2020 Jul; 111(7):2431-2439. PubMed ID: 32415892
[TBL] [Abstract] [Full Text] [Related]
9. Hypoxia promotes migration and invasion of gastric cancer cells by activating HIF-1α and inhibiting NDRG2 associated signaling pathway.
Ou XW; Wang RX; Kang MF; Shi JQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8237-8247. PubMed ID: 30556863
[TBL] [Abstract] [Full Text] [Related]
10. The prognostic value of decreased NDRG1 expression in patients with digestive system cancers: A meta-analysis.
Chen K; Liu XH; Wang FR; Liu HP; Huang ZP; Chen X
Medicine (Baltimore); 2018 Oct; 97(41):e12455. PubMed ID: 30313035
[TBL] [Abstract] [Full Text] [Related]
11. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.
Hu XY; Liu Z; Zhang KL; Feng J; Liu XF; Wang LY; Wang ZW
Cancer Biomark; 2017 Dec; 21(1):195-201. PubMed ID: 29060933
[TBL] [Abstract] [Full Text] [Related]
12. NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers.
Yamamura A; Miura K; Karasawa H; Motoi F; Mizuguchi Y; Saiki Y; Fukushige S; Sunamura M; Shibata C; Unno M; Horii A
Biochem Biophys Res Commun; 2017 Feb; 484(1):138-143. PubMed ID: 28093228
[TBL] [Abstract] [Full Text] [Related]
13. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.
Chen X; Yang Y; Liu J; Li B; Xu Y; Li C; Xu Q; Liu G; Chen Y; Ying J; Duan S
Oncotarget; 2017 Jan; 8(5):8105-8119. PubMed ID: 28042954
[TBL] [Abstract] [Full Text] [Related]
14. n-myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-κB/p65.
Hou J; Wang T; Xie Q; Deng W; Yang JY; Zhang SQ; Cai JC
Cancer Lett; 2016 Jun; 376(1):22-33. PubMed ID: 27012186
[TBL] [Abstract] [Full Text] [Related]
15. The potential of deferasirox as a novel therapeutic modality in gastric cancer.
Choi JH; Kim JS; Won YW; Uhm J; Park BB; Lee YY
World J Surg Oncol; 2016 Mar; 14():77. PubMed ID: 26965928
[TBL] [Abstract] [Full Text] [Related]
16. [Expressions and significance of NDRG2 and Bcl-2 in human gastric cancer tissues].
Zhu R; Shi Y; Zhang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Apr; 31(4):516-9. PubMed ID: 25854572
[TBL] [Abstract] [Full Text] [Related]
17. Ndrg2 promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma.
Ling ZQ; Ge MH; Lu XX; Han J; Wu YC; Liu X; Zhu X; Hong LL
Oncotarget; 2015 Apr; 6(10):8210-25. PubMed ID: 25823664
[TBL] [Abstract] [Full Text] [Related]
18. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor.
Kanda T; Miyata M; Kano M; Kondo S; Yoshizaki T; Iizasa H
J Virol; 2015 Mar; 89(5):2684-97. PubMed ID: 25520514
[TBL] [Abstract] [Full Text] [Related]
19. NDRG1 expression is related to the progression and prognosis of gastric cancer patients through modulating proliferation, invasion and cell cycle of gastric cancer cells.
Chang X; Xu X; Ma J; Xue X; Li Z; Deng P; Zhang S; Zhi Y; Chen J; Dai D
Mol Biol Rep; 2014 Sep; 41(9):6215-23. PubMed ID: 24985974
[TBL] [Abstract] [Full Text] [Related]
20. Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study.
Espinosa-Parrilla Y; Muñoz X; Bonet C; Garcia N; Venceslá A; Yiannakouris N; Naccarati A; Sieri S; Panico S; Huerta JM; Barricarte A; Menéndez V; Sánchez-Cantalejo E; Dorronsoro M; Brennan P; Duarte-Salles T; B As Bueno-de-Mesquita H; Weiderpass E; Lund E; Clavel-Chapelon F; Boutron-Ruault MC; Racine A; Numans ME; Tumino R; Canzian F; Campa D; Sund M; Johansson M; Ohlsson B; Lindkvist B; Overvad K; Tjønneland A; Palli D; Travis RC; Khaw KT; Wareham N; Boeing H; Nesi G; Riboli E; Gonzalez CA; Sala N
Int J Cancer; 2014 Nov; 135(9):2065-76. PubMed ID: 24643999
[TBL] [Abstract] [Full Text] [Related]
[Next]
